POINT BIOPHARMA Trademark
Serial Number: 90093341
POINT BIOPHARMA is a trademark filed by
Point Biopharma Corp.
on August 4, 2020. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently no longer active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
John R. Rudolph Eli Lilly and Company
Lilly Corporate Center
Indianapolis, IN 46285
United States
Trademark Details
Filing Date
August 4, 2020
Registration Date
Not Registered
Goods & Services
Pharmaceutical preparations for the diagnosis and treatment of cancer and tumors; pharmaceutical preparations for the diagnosis and treatment of oncological diseases; radioactive pharmaceutical substances for use in nuclear medicine, intended for medical treatments and imaging; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
Filing History
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Feb 10, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Feb 10, 2025 ABN2
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Oct 29, 2024 RCCK
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Oct 22, 2024 GNS2
INQUIRY TO SUSPENSION E-MAILED
Oct 22, 2024 GNSI
SUSPENSION INQUIRY WRITTEN
Oct 22, 2024 CNSI
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 12, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 12, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 12, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 12, 2024 REAP
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 11, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 11, 2023 GNSL
SUSPENSION LETTER WRITTEN
Dec 11, 2023 CNSL
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 13, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 13, 2023 GNSL
SUSPENSION LETTER WRITTEN
Jun 13, 2023 CNSL
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 13, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 13, 2022 GNSL
SUSPENSION LETTER WRITTEN
Dec 13, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 12, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 12, 2022 CRFA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 12, 2022 CHAN
ASSIGNED TO LIE
Dec 12, 2022 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Dec 5, 2022 ERSI
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 7, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 7, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 7, 2022 REAP
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jun 6, 2022 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jun 6, 2022 GNSI
SUSPENSION INQUIRY WRITTEN
Jun 6, 2022 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jun 3, 2022 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 1, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 1, 2021 GNSL
SUSPENSION LETTER WRITTEN
Nov 1, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 1, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 1, 2021 CRFA
ASSIGNED TO LIE
Oct 28, 2021 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Oct 22, 2021 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Aug 19, 2021 GNS2
INQUIRY TO SUSPENSION E-MAILED
Aug 19, 2021 GNSI
SUSPENSION INQUIRY WRITTEN
Aug 19, 2021 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Aug 18, 2021 RCCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 11, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 11, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 11, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 11, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 11, 2021 COAR
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 24, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 24, 2020 GNSL
SUSPENSION LETTER WRITTEN
Nov 24, 2020 CNSL
EXAMINER'S AMENDMENT ENTERED
Nov 24, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 24, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 24, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 24, 2020 CNEA
ASSIGNED TO EXAMINER
Nov 24, 2020 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 4, 2020 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 3, 2020 NWOS
NEW APPLICATION ENTERED
Aug 7, 2020 NWAP
